Retraction Note: Oral nutritional supplement prevents weight loss and reduces side effects in patients in advanced lung cancer chemotherapy.

Save

Retraction Note: Amino Acids (2020) 52:445–451

https://doi.org/10.1007/s00726-020-02822-7

The Editors-in-Chief have retracted this article.

Following publication, concerns were raised regarding the lack of ethics approval for this study. The authors were contacted to provide documentation and clarification, but they failed to respond.

None of authors has responded to any correspondence from Publisher regarding this retraction.

Related articles

PubMed

Cascade-responsive HA-decorated liposome/mesoporous silica nanoplatform co-delivering BMF-219 and 5-FU enhances gastric cancer chemotherapy through Menin- and p53-associated apoptotic signaling.

Background Our preliminary study found that Men1 is an oncogene and a potential therapeutic target in gastric cancer (GC). Chemotherapy remains a common therapeutic regimen for GC, but is frequently limited by multidrug resistance and poor intratumoral coordination of combination drugs. Targeting Menin may enhance chemotherapy sensitivity, but efficient co-delivery of Menin inhibitors and chemotherapeutics is hindered by the profound spatiotemporal pharmacokinetic decoupling of the drugs in viv...

PubMed

pH-responsive chitosan-mesoporous organosilica nanoplatform: enhancement of biocompatibility and tumor eradication for precision colorectal cancer chemotherapy.

Chemotherapy for colorectal cancer (CRC) is frequently compromised by insufficient tumor selectivity and severe off-target gastrointestinal toxicity. Addressing these limitations, we have engineered a pH-responsive core–shell nanocarrier based on chitosan (CS)-functionalized mesoporous organosilica materials (CS-MOMs). This core-shell nanoplatform utilize a CS coating as a pH-sensitive gatekeeper enabling rapid doxorubicin (DOX) release within the acidic tumor microenvironment and lysosomal comp...